The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in revenue , its exclusivity period created a wave of https://adsbookmark.com/story21507432/sildenafil-and-the-pharmaceutical-sector-a-risky-opportunity